Medicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver.
Ari Feuer, BS
Advertisement
Articles by Ari Feuer, BS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
Brensocatib Reduced Symptom Burden, Neutrophil Serine Proteases Activity in Bronchiectasis
3
Pembrolizumab Plus Chemo Boosts PFS, OS in Platinum-Resistant Recurrent Ovarian Cancer: Nicoletta Colombo, MD, PhD
4
Long-Term Data for PHAROS Show Half of Treatment-Naïve Patients Receiving Encorafenib Plus Binimetinib Alive at 4 Years
5
